TrialThe oncologist2021

Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study.

F J Sherida H Woei-A-Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.